Keywords: HLM ها; CV; coefficients of variation; eROS; enzymatic reactive oxygen species; FA; fenofibric acid; FF; fenofibrate; HLMs; human liver microsomes; mROS; micellar reactive oxygen species; NaPB; sodium phosphate buffer; NBT; nitroblue tetrazolium; ROS; reactive ox
مقالات ISI HLM ها (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Metabolic profiling of five flavonoids from Dragon's Blood in human liver microsomes using high-performance liquid chromatography coupled with high resolution mass spectrometry
Keywords: HLM ها; CYPs; cytochrome P450s; DB; Dragon's Blood; HLMs; human liver microsomes; HPLC-HR-MS; high performance liquid chromatography coupled with high resolution mass spectrometry; tR; retention time; Dragon's Blood; Human liver microsomes; HPLC-HR-MS; Metabolite
Keywords: HLM ها; Choquet; Subset characterization; HLMS; Generalized Shapley index
Drug interaction study of flavonoids toward CYP3A4 and their quantitative structure activity relationship (QSAR) analysis for predicting potential effects
Keywords: HLM ها; CYPs; cytochrome P450s; HDIs; herb-drug interactions; HLMs; human liver microsomes; NADPï¼; β-nicotinamide adenine dinucleotide phosphate; QSAR; quantitative structure activity relationship; CoMFA; comparative molecular field analysis; LC-MS; liquid c
Inhibitory Effects of Danshen components on CYP2C8 and CYP2J2
Keywords: HLM ها; Cytochrome P450; Inhibitory effects; Danshen; CYP2C8; CYP2J2; Herb-drug interactions; AA; arachidonic acid; CA; caffeic acid; Cry; cryptotanshinone; CYPs; Cytochrome P450 enzymes; DSS; danshensu; DI; dihydrotanshinone I; EETs; epoxyeicosatrienoic acids; F
A systematic review of pharmacokinetic studies on herbal drug Fuzi: Implications for Fuzi as personalized medicine
Keywords: HLM ها; Aconitum carmichaeli Debx.; Aconitum alkaloids; Pharmacokinetics; Herb-drug interactions; Toxicology; Personalized medicine; DMEs; drug-metabolizing enzymes; ETs; efflux transporters; BB; bioavailability barrier; DDAs; diester-diterpene alkaloids; MDAs; m
Identification of acetylshikonin as the novel CYP2J2 inhibitor with anti-cancer activity in HepG2 cells
Keywords: HLM ها; Acetylshikonin; CYP2J2; Inhibition; Anti-cancer; HLMs; human liver microsomes; HCC; Hepatocellular carcinoma; DMSO; dimethyl sulfoxide; G6P; glucose-6-phosphate; G6PDH; G6P dehydrogenase; NADP+; β-nicotinamide dinucleotide phosphate; EETs; Epoxyeicosatri
Effects of diosmetin on nine cytochrome P450 isoforms, UGTs and three drug transporters in vitro
Keywords: HLM ها; Diosmetin; Cytochrome P450; UDP-glucuronyltransferases; Hepatic uptake transporters; Drug-drug interactions; CYPs; Cytochrome P450 enzymes; DDI; drug-drug interactions; HDI; herb-drug interactions; HLMs; human liver microsomes; NTCP; Na+-taurocholate cotr
Efficient substrate screening and inhibitor testing of human CYP4Z1 using permeabilized recombinant fission yeast
Keywords: HLM ها; ADMET; absorption, distribution, metabolism, excretion, and toxicity; API; active pharmaceutical ingredient; CPR; NADPH-cytochrome P450 oxidoreductase; CYP; cytochrome P450; EMM; Edinburgh Minimal Medium; HLMs; human liver microsomes; RLU; relative lumine
k-maxitive fuzzy measures: A scalable approach to model interactions
Keywords: HLM ها; Choquet; Fuzzy measure; HLMS; Shapley; Möbius; k-order measures;
Identification and characterization of human UDP-glucuronosyltransferases responsible for the in vitro glucuronidation of ursolic acid
Keywords: HLM ها; Ursolic acid; UDP-glucuronosyltransferases; Metabolism pathway; Metabolism characterization; UA; ursolic acid; HLMs; human liver microsomes; HIMs; human intestinal microsomes; UGTs; UDP-glucuronosyltransferases; DDI; drug-drug interactions; RILD; Resear
Optical isomers of dihydropyridine calcium channel blockers display enantiospecific effects on the expression and enzyme activities of human xenobiotics-metabolizing cytochromes P450
Keywords: HLM ها; AhR; Aryl Hydrocarbon Receptor; CCBs; calcium channel blockers; CYP; cytochrome P450; DEX; dexamethasone; DMSO; dimethysulfoxide; GR; Glucocorticoid Receptor; HLMs; human liver microsomes; PXR; pregnane X receptor; RIF; rifampicin; TCDD; 2,3,7,8 tetrachlo
Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2
Keywords: HLM ها; MBI; mechanism-based inhibition; RMs; reactive metabolites; CYPs; cytochrome P450 enzymes; GSH; reduced glutathione; HLMs; human liver microsomes; NADPH; β-nicotinamide adenine dinucleotide 2'-phosphate reduced tetrasodium salt; MI complex; metabolite
Regioselective glucuronidation of the isoflavone calycosin by human liver microsomes and recombinant human UDP-glucuronosyltransferases
Keywords: HLM ها; HLMs; human liver microsomes; UGTs; UDP-glucuronosyltransferases; SGR; Structure-glucuronidation relationship; HPLC; high performance liquid chromatography; NADPH; nicotinamide adenine dinucleotide phosphate reduced; CYP450s; cytochrome P450s; PAPS; 3â
Synthesis of acylated glycoconjugates as templates to investigate in vitro biopharmaceutical properties
Keywords: HLM ها; CuAAC; copper-catalysed azide-alkyne cycloaddition; CE; carboxylesterase; c log P; calculated Log P; HLMs; human liver microsomes; HSA; human serum albumin; CYP450; cytochrome P450; Carbohydrate; Prodrug; Esterase; Metabolic stability; Click chemistr
Drug metabolism by CYP2C8.3 is determined by substrate dependent interactions with cytochrome P450 reductase and cytochrome b5
Keywords: HLM ها; CYP; cytochrome P450; CPR; cytochrome P450 reductase; CER; cerivastatin; AQ; amodiaquine; PAC; paclitaxel; RG; rosiglitazone; DEAQ; N-de ethyl amodiaquine; DLPC; L-α-dilauryl-sn-glycero-3-phosphocholine; HLMs; human liver microsomes; SIR EI+; selective i